Top Markets
#1 Prom Prom +36.01%
#2 QuantixAI QuantixAI +31.15%
#3 MowCat MowCat +27.85%
#4 UnifAI Network UnifAI Network +23.33%
#5 Tutorial Tutorial +19.31%
#6 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +18.53%
#7 Pons Pons +17.42%
#8 Versatize Coin Versatize Coin +16.65%
#9 Derive Derive +13.93%
#10 GEKKO GEKKO +13.35%
Coin of the day
Prom Prom
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Captor Therapeutics Spolka Akcyjna Captor Therapeutics Spolka Akcyjna

Captor Therapeutics Spolka Akcyjna

CTX
Clasificación en acciones #20515
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the... Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. Its products in various stages of development include CT-03, which has completed the Phase 1 clinical trials for the treatment of non-small cell lung cancer, triple-negative breast cancer, as well as cancers of the blood, lymphatic system, and bone marrow; and CT-01, which also completed the Phase 1 clinical trials for the treatment of hepatocellular carcinoma, through degradation of oncofetal transcription factor. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.
Precio por acción
$20.38
Capitalización bursátil
$129.09M
Cambio (1 día)
-0.82%
Cambio (1 año)
80.91%
País
PL
Comercio Captor Therapeutics Spolka Akcyjna (CTX)

Categoría

Healthcare
Ratio P/B de Captor Therapeutics Spolka Akcyjna (CTX)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Captor Therapeutics Spolka Akcyjna, el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Captor Therapeutics Spolka Akcyjna desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH